コルチコステロイドAPIの世界市場レポート2025-2031

QY Research > レポート一覧 > 化学及び材料 > コルチコステロイドAPIの世界市場レポート2025-2031

英文タイトル： Global Adrenocortical Hormones API Market Insights, Forecast to 2031

レポートID：987556
発表時期：2025-02-12
訪問回数：358
ページ数：197
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：185
レポートカテゴリ：化学及び材料

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.50円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.50円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、コルチコステロイドAPIの世界市場について、容量、生産量、収益、価格の概要を紹介します。2021年から2025年までの過去の市場収益/売上データ、2026年の予測データ、ならびに2032年までのCAGR（年平均成長率）予測を含む、世界市場動向の分析を提供します。本レポートは、メーカー、地域、製品種類、およびエンドユーザー産業の観点から、世界と主要地域の市場現状と将来性を研究したものです。世界と主要地域のトップメーカーを分析し、製品タイプおよびアプリケーション/エンドユーザー産業別にコルチコステロイドAPI市場を分類しています。

本レポートでは、世界のコルチコステロイドAPI市場の主要参加企業として、企業概要、販売数量、収益、価格、粗利益率、製品ポートフォリオ、地理的位置、主要な事業展開を以下のパラメータに基づいて紹介します。
本レポートはコルチコステロイドAPIの主要生産者を調査するとともに、主要地域や国の消費状況も提供します。コルチコステロイドAPIの主要地域／国における将来の市場ポテンシャルを重点的に分析し、それに基づき、異なるセグメントおよびサブセグメントにおける市場の将来動向を予測しております。アメリカ、カナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、その他の国々について、各国データおよび市場価値分析を提供しております。
2021年から2032年までの期間について、タイプ別および用途別の売上高、収益、価格に基づくセグメントデータを分析します。

本研究に含まれる主な企業は以下の通りです：
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
Teva Pharmaceutical Industries
Hovione
Axplora
Steroid SpA
Avik Pharmaceutical
Anuh Pharma
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Wellona Pharma
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Guangdong Vtr Bio-Tech
Zhejiang Xianju Xianle Pharmaceutical
TIANJIN PACIFIC PHARMACEUTICAL
Shandong Xinhua Pharmaceutica Group
Jiangsu Lianhuan Pharmaceutical
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Saituo Biological Technology
Zhejiang Xianju Junye Pharmaceutical

タイプ別市場セグメント：
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others

用途別市場セグメント：
Injectable Drugs
Oral Drugs
Topical Drugs
Inhaled Drugs

地域別の市場セグメント：
北米
アジア太平洋
欧州
中南米
中東・アフリカ

本レポートの詳細内容：
世界のコルチコステロイドAPI市場の現状と将来展望を包括的に分析し、グローバル主要地域における開発動向の綿密な調査を通じて、企業様に包括的な市場分析を提示します。市場の全体像を把握するため、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてコルチコステロイドAPI市場を細分化しています。この分類と用途分析により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2021年から2026年までの実績と2032年までの予測として、メーカー別、地域別（地域レベル、国レベル）のコルチコステロイドAPI生産量、成長率、市場シェアを調査しています。
二. 消費面では、コルチコステロイドAPIの売上高について、地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2021年から2026年まで、および2032年までの予測を対象とします。
三. 主要メーカーのコルチコステロイドAPI売上高、収益、市場シェア、業界ランキングについて、2021年から2026年までのデータに焦点を当てています。世界のコルチコステロイドAPI市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づく競争状況と市場ポジショニングの分析を行います。
四. 本コルチコステロイドAPIレポートは、関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立案するのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業に関する市場規模の詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章節目次：
第1章：コルチコステロイドAPIレポートの範囲、市場セグメント（タイプ別、用途別など）ごとの市場規模、将来の発展可能性などをまとめたエグゼクティブサマリーをご紹介いたします。これにより、市場の最新状況を包括的に把握し、短期・中期・長期（2021-2032年）にわたる発展の見通しを把握いただけます。
第2章：コルチコステロイドAPIの世界および主要生産者（地域／国別）の生産量／アウトプットについて分析します。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています（2021年～2032年）
第3章：コルチコステロイドAPIの現在の市場状況を提示し、2032年までの世界的な収益・販売・生産を予測するとともに、消費量の多い地域と新興市場の成長要因を特定します（2021年～2032年）
第4章：コルチコステロイドAPIメーカーの競争状況、価格、売上高、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報など詳細に分析します（2021年～2026年）
第5章：コルチコステロイドAPIの下流市場機会を特定し、用途別販売量・収益・価格設定を評価するとともに新興ユースケースを明らかにし、地域別・用途別の主要顧客をプロファイリングします
第6章：コルチコステロイドAPIのグローバル生産能力、稼働率、市場シェア（2021-2032年）をマッピングし、効率的拠点を特定するとともに規制や貿易政策の影響とボトルネックを解明します
第7章：北米におけるコルチコステロイドAPI市場をアプリケーション別・国別売上高・収益で分析し、主要メーカーをプロファイリングしつつ成長要因と障壁を評価します
第8章：欧州におけるコルチコステロイドAPI市場をアプリケーション別・メーカー別に地域別売上高・収益・市場分析を行い、成長要因と障壁を明示します
第9章：アジア太平洋地域のコルチコステロイドAPI市場を用途別・地域/国別の売上高と収益で定量化し、主要メーカーをプロファイリングするとともに高成長潜在地域を明らかにします
第10章：中南米におけるコルチコステロイドAPI市場を用途別・国別売上高と収益で測定し、主要メーカーをプロファイリングするとともに投資機会と課題を特定します
第11章：中東・アフリカ地域のコルチコステロイドAPI市場を用途別・国別に評価し、主要メーカーをプロファイリングするとともに投資見通しと市場障壁を概説します
第12章：コルチコステロイドAPIの主要メーカーの概要を提供し、製品説明、売上高、収益、価格、粗利益率、最近の事業拡大などの情報を整理するとともに、SWOT分析および戦略動向分析を行います
第13章：コルチコステロイドAPIのサプライチェーンを分析し、上流の原材料・供給業者、製造拠点と技術、コスト要因を明らかにします
第14章：コルチコステロイドAPIの市場動向、最新動向、推進要因と制約要因、業界内のメーカーが直面する課題とリスク、関連する業界政策の分析を紹介します
第15章：レポートの要点と結論
第16章：付録

Description

Valued at US$ 2711 million in 2024, the global Adrenocortical Hormones API market is forecast to reach US$ 3892 million by 2030, at a CAGR of 6.2% during the forecast period.

Adrenocortical hormones active pharmaceutical ingredients (APIs) refer to the raw materials used in the production of corticosteroid drugs. These hormones are synthesized in the adrenal cortex and play a crucial role in regulating metabolism, immune response, and stress adaptation. Common adrenocortical hormone APIs include hydrocortisone, prednisone, dexamethasone, and betamethasone, which are widely used in the treatment of inflammatory diseases, autoimmune disorders, and endocrine dysfunctions. The production of these APIs involves complex chemical synthesis or semi-synthetic processes derived from steroid precursors, often sourced from plant sterols. Due to their essential medical applications, adrenocortical hormone APIs are subject to strict quality control and regulatory compliance to ensure their efficacy and safety.

Adrenocortical hormone drugs are widely used for anti-inflammatory, immunosuppressive, and endocrine disease treatments, with stable and growing market demand. Historically, the global steroid drug industry has been dominated by major multinational pharmaceutical companies from Europe and the United States, such as Pfizer, Bayer, Merck, and Sanofi. These companies hold key technologies and have a strong presence in high-end markets. However, in recent years, China has emerged as a major production hub for steroid drugs due to its advantages in raw material supply, lower production costs, and continuous improvements in manufacturing technology. As a result, China has become an increasingly significant player in the global adrenocortical hormone API market.As the pharmaceutical industry continues to globalize, the supply chain for steroid drugs is becoming more optimized. Chinese manufacturers are advancing in industrial upgrading and quality control, driving the sector towards greater standardization and higher value-added products. Additionally, stricter environmental regulations and improved production standards are pushing companies toward green manufacturing and better compliance management, further strengthening China’s competitiveness in the global market. Moreover, rising aging populations and increasing prevalence of chronic diseases worldwide are expected to sustain demand for adrenocortical hormone drugs, creating further growth opportunities for the industry.Several factors are driving the industry's growth. Firstly, breakthroughs in fermentation and chemical synthesis technologies have lowered production costs, enhancing global competitiveness. Secondly, Chinese manufacturers have made significant progress in quality control and international certifications, enabling easier entry into high-end markets in Europe and the United States. Additionally, multinational pharmaceutical companies are increasingly relying on Chinese suppliers to optimize their production costs and supply chain efficiency, accelerating the industry's shift toward China.However, the industry also faces challenges. Stricter environmental regulations worldwide are increasing operational costs for some manufacturers. Additionally, changes in international trade policies and intellectual property rights protection could impact Chinese companies' export competitiveness. Furthermore, technical barriers in high-end markets remain, requiring Chinese companies to further invest in core patents, brand influence, and premium product development.

In terms of production side, this report researches the Adrenocortical Hormones API production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Adrenocortical Hormones API by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

This report presents an overview of global market for Adrenocortical Hormones API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Adrenocortical Hormones API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Adrenocortical Hormones API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Adrenocortical Hormones API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Adrenocortical Hormones API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Adrenocortical Hormones API sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Pfizer CentreOne, EUROAPI, GlaxoSmithKline, Teva Pharmaceutical Industries, Hovione, Axplora, Steroid SpA, Avik Pharmaceutical, Anuh Pharma, Symbiotec Pharmalab, etc.

Market Segmentation
By Company
Pfizer CentreOne
EUROAPI
GlaxoSmithKline
Teva Pharmaceutical Industries
Hovione
Axplora
Steroid SpA
Avik Pharmaceutical
Anuh Pharma
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Wellona Pharma
Tianjin Tianyao Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Guangdong Vtr Bio-Tech
Zhejiang Xianju Xianle Pharmaceutical
TIANJIN PACIFIC PHARMACEUTICAL
Shandong Xinhua Pharmaceutica Group
Jiangsu Lianhuan Pharmaceutical
Shanghai New Hualian Pharmaceutical
Shandong Taihua Biotech
Saituo Biological Technology
Zhejiang Xianju Junye Pharmaceutical

Segment by Type
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others

Segment by Application
Injectable Drugs
Oral Drugs
Topical Drugs
Inhaled Drugs

Production by Region
North America
Europe
China
Japan
Southeast Asia
India

Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia

Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Adrenocortical Hormones API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Adrenocortical Hormones API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Adrenocortical Hormones API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adrenocortical Hormones API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

Table of Contents

1 Study Coverage
1.1 Adrenocortical Hormones API Product Introduction
1.2 Market by Type
1.2.1 Global Adrenocortical Hormones API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Prednisone Series
1.2.3 Dexamethasone Series
1.2.4 Betamethasone Series
1.2.5 Hydrocortisone Series
1.2.6 Others
1.3 Market by Application
1.3.1 Global Adrenocortical Hormones API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injectable Drugs
1.3.3 Oral Drugs
1.3.4 Topical Drugs
1.3.5 Inhaled Drugs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Adrenocortical Hormones API Production
2.1 Global Adrenocortical Hormones API Production Capacity (2020-2031)
2.2 Global Adrenocortical Hormones API Production by Region: 2020 VS 2024 VS 2031
2.3 Global Production by Region
2.3.1 Global Adrenocortical Hormones API Production by Region (2020-2031)
2.3.2 Global Adrenocortical Hormones API Production Market Share by Region (2020-2031)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 Southeast Asia
2.9 India

3 Executive Summary
3.1 Global Adrenocortical Hormones API Revenue Estimates and Forecasts 2020-2031
3.2 Global Revenue by Region
3.2.1 Global Adrenocortical Hormones API Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Adrenocortical Hormones API Revenue by Region (2020-2031)
3.2.3 Global Adrenocortical Hormones API Revenue Market Share by Region (2020-2031)
3.3 Global Adrenocortical Hormones API Sales Estimates and Forecasts 2020-2031
3.4 Global Sales by Region
3.4.1 Global Adrenocortical Hormones API Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Adrenocortical Hormones API Sales by Region (2020-2031)
3.4.3 Global Adrenocortical Hormones API Sales Market Share by Region (2020-2031)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America

4 Competition by Manufacturers
4.1 Global Sales by Manufacturers
4.1.1 Global Adrenocortical Hormones API Sales by Manufacturers (2020-2025)
4.1.2 Global Adrenocortical Hormones API Sales Market Share by Manufacturers (2020-2025)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Adrenocortical Hormones API in 2024
4.2 Global Revenue by Manufacturers
4.2.1 Global Adrenocortical Hormones API Revenue by Manufacturers (2020-2025)
4.2.2 Global Adrenocortical Hormones API Revenue Market Share by Manufacturers (2020-2025)
4.2.3 Global Top 10 and Top 5 Companies by Adrenocortical Hormones API Revenue in 2024
4.3 Global Adrenocortical Hormones API Sales Price by Manufacturers (2020-2025)
4.4 Global Key Players of Adrenocortical Hormones API, Industry Ranking, 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Adrenocortical Hormones API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Adrenocortical Hormones API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Adrenocortical Hormones API, Product Offered and Application
4.8 Global Key Manufacturers of Adrenocortical Hormones API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global Sales by Type
5.1.1 Global Adrenocortical Hormones API Historical Sales by Type (2020-2025)
5.1.2 Global Adrenocortical Hormones API Forecasted Sales by Type (2026-2031)
5.1.3 Global Adrenocortical Hormones API Sales Market Share by Type (2020-2031)
5.2 Global Revenue by Type
5.2.1 Global Adrenocortical Hormones API Historical Revenue by Type (2020-2025)
5.2.2 Global Adrenocortical Hormones API Forecasted Revenue by Type (2026-2031)
5.2.3 Global Adrenocortical Hormones API Revenue Market Share by Type (2020-2031)
5.3 Global Price by Type
5.3.1 Global Adrenocortical Hormones API Price by Type (2020-2025)
5.3.2 Global Adrenocortical Hormones API Price Forecast by Type (2026-2031)

6 Market Size by Application
6.1 Global Sales by Application
6.1.1 Global Adrenocortical Hormones API Historical Sales by Application (2020-2025)
6.1.2 Global Adrenocortical Hormones API Forecasted Sales by Application (2026-2031)
6.1.3 Global Adrenocortical Hormones API Sales Market Share by Application (2020-2031)
6.2 Global Revenue by Application
6.2.1 Global Adrenocortical Hormones API Historical Revenue by Application (2020-2025)
6.2.2 Global Adrenocortical Hormones API Forecasted Revenue by Application (2026-2031)
6.2.3 Global Adrenocortical Hormones API Revenue Market Share by Application (2020-2031)
6.3 Global Price by Application
6.3.1 Global Adrenocortical Hormones API Price by Application (2020-2025)
6.3.2 Global Adrenocortical Hormones API Price Forecast by Application (2026-2031)

7 US & Canada
7.1 US & Canada Market Size by Type
7.1.1 US & Canada Adrenocortical Hormones API Sales by Type (2020-2031)
7.1.2 US & Canada Adrenocortical Hormones API Revenue by Type (2020-2031)
7.2 US & Canada Market Size by Application
7.2.1 US & Canada Adrenocortical Hormones API Sales by Application (2020-2031)
7.2.2 US & Canada Adrenocortical Hormones API Revenue by Application (2020-2031)
7.3 US & Canada Market Size by Country
7.3.1 US & Canada Adrenocortical Hormones API Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 US & Canada Adrenocortical Hormones API Revenue by Country (2020-2031)
7.3.3 US & Canada Adrenocortical Hormones API Sales by Country (2020-2031)
7.3.4 US
7.3.5 Canada

8 Europe
8.1 Europe Market Size by Type
8.1.1 Europe Adrenocortical Hormones API Sales by Type (2020-2031)
8.1.2 Europe Adrenocortical Hormones API Revenue by Type (2020-2031)
8.2 Europe Market Size by Application
8.2.1 Europe Adrenocortical Hormones API Sales by Application (2020-2031)
8.2.2 Europe Adrenocortical Hormones API Revenue by Application (2020-2031)
8.3 Europe Market Size by Country
8.3.1 Europe Adrenocortical Hormones API Revenue by Country: 2020 VS 2024 VS 2031
8.3.2 Europe Adrenocortical Hormones API Sales by Country (2020-2031)
8.3.3 Europe Adrenocortical Hormones API Revenue by Country (2020-2031)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia

9 China
9.1 China Market Size by Type
9.1.1 China Adrenocortical Hormones API Sales by Type (2020-2031)
9.1.2 China Adrenocortical Hormones API Revenue by Type (2020-2031)
9.2 China Market Size by Application
9.2.1 China Adrenocortical Hormones API Sales by Application (2020-2031)
9.2.2 China Adrenocortical Hormones API Revenue by Application (2020-2031)

10 Asia (excluding China)
10.1 Asia Market Size by Type
10.1.1 Asia Adrenocortical Hormones API Sales by Type (2020-2031)
10.1.2 Asia Adrenocortical Hormones API Revenue by Type (2020-2031)
10.2 Asia Market Size by Application
10.2.1 Asia Adrenocortical Hormones API Sales by Application (2020-2031)
10.2.2 Asia Adrenocortical Hormones API Revenue by Application (2020-2031)
10.3 Asia Market Size by Region
10.3.1 Asia Adrenocortical Hormones API Revenue by Region: 2020 VS 2024 VS 2031
10.3.2 Asia Adrenocortical Hormones API Revenue by Region (2020-2031)
10.3.3 Asia Adrenocortical Hormones API Sales by Region (2020-2031)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India

11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Market Size by Type
11.1.1 Middle East, Africa and Latin America Adrenocortical Hormones API Sales by Type (2020-2031)
11.1.2 Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Type (2020-2031)
11.2 Middle East, Africa and Latin America Market Size by Application
11.2.1 Middle East, Africa and Latin America Adrenocortical Hormones API Sales by Application (2020-2031)
11.2.2 Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Application (2020-2031)
11.3 Middle East, Africa and Latin America Market Size by Country
11.3.1 Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Country: 2020 VS 2024 VS 2031
11.3.2 Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Country (2020-2031)
11.3.3 Middle East, Africa and Latin America Adrenocortical Hormones API Sales by Country (2020-2031)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries

12 Corporate Profile
12.1 Pfizer CentreOne
12.1.1 Pfizer CentreOne Corporation Information
12.1.2 Pfizer CentreOne Overview
12.1.3 Pfizer CentreOne Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.4 Pfizer CentreOne Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Pfizer CentreOne Recent Developments
12.2 EUROAPI
12.2.1 EUROAPI Corporation Information
12.2.2 EUROAPI Overview
12.2.3 EUROAPI Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.4 EUROAPI Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 EUROAPI Recent Developments
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Corporation Information
12.3.2 GlaxoSmithKline Overview
12.3.3 GlaxoSmithKline Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.4 GlaxoSmithKline Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 GlaxoSmithKline Recent Developments
12.4 Teva Pharmaceutical Industries
12.4.1 Teva Pharmaceutical Industries Corporation Information
12.4.2 Teva Pharmaceutical Industries Overview
12.4.3 Teva Pharmaceutical Industries Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.4 Teva Pharmaceutical Industries Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Teva Pharmaceutical Industries Recent Developments
12.5 Hovione
12.5.1 Hovione Corporation Information
12.5.2 Hovione Overview
12.5.3 Hovione Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.4 Hovione Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Hovione Recent Developments
12.6 Axplora
12.6.1 Axplora Corporation Information
12.6.2 Axplora Overview
12.6.3 Axplora Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.4 Axplora Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Axplora Recent Developments
12.7 Steroid SpA
12.7.1 Steroid SpA Corporation Information
12.7.2 Steroid SpA Overview
12.7.3 Steroid SpA Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.4 Steroid SpA Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Steroid SpA Recent Developments
12.8 Avik Pharmaceutical
12.8.1 Avik Pharmaceutical Corporation Information
12.8.2 Avik Pharmaceutical Overview
12.8.3 Avik Pharmaceutical Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.4 Avik Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Avik Pharmaceutical Recent Developments
12.9 Anuh Pharma
12.9.1 Anuh Pharma Corporation Information
12.9.2 Anuh Pharma Overview
12.9.3 Anuh Pharma Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.4 Anuh Pharma Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Anuh Pharma Recent Developments
12.10 Symbiotec Pharmalab
12.10.1 Symbiotec Pharmalab Corporation Information
12.10.2 Symbiotec Pharmalab Overview
12.10.3 Symbiotec Pharmalab Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.4 Symbiotec Pharmalab Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Symbiotec Pharmalab Recent Developments
12.11 Sun Pharmaceutical
12.11.1 Sun Pharmaceutical Corporation Information
12.11.2 Sun Pharmaceutical Overview
12.11.3 Sun Pharmaceutical Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.4 Sun Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Sun Pharmaceutical Recent Developments
12.12 Cipla
12.12.1 Cipla Corporation Information
12.12.2 Cipla Overview
12.12.3 Cipla Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.4 Cipla Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Cipla Recent Developments
12.13 Wellona Pharma
12.13.1 Wellona Pharma Corporation Information
12.13.2 Wellona Pharma Overview
12.13.3 Wellona Pharma Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.4 Wellona Pharma Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Wellona Pharma Recent Developments
12.14 Tianjin Tianyao Pharmaceuticals
12.14.1 Tianjin Tianyao Pharmaceuticals Corporation Information
12.14.2 Tianjin Tianyao Pharmaceuticals Overview
12.14.3 Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.4 Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Tianjin Tianyao Pharmaceuticals Recent Developments
12.15 Zhejiang Xianju Pharmaceutical
12.15.1 Zhejiang Xianju Pharmaceutical Corporation Information
12.15.2 Zhejiang Xianju Pharmaceutical Overview
12.15.3 Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.4 Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Zhejiang Xianju Pharmaceutical Recent Developments
12.16 Guangdong Vtr Bio-Tech
12.16.1 Guangdong Vtr Bio-Tech Corporation Information
12.16.2 Guangdong Vtr Bio-Tech Overview
12.16.3 Guangdong Vtr Bio-Tech Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.4 Guangdong Vtr Bio-Tech Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Guangdong Vtr Bio-Tech Recent Developments
12.17 Zhejiang Xianju Xianle Pharmaceutical
12.17.1 Zhejiang Xianju Xianle Pharmaceutical Corporation Information
12.17.2 Zhejiang Xianju Xianle Pharmaceutical Overview
12.17.3 Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.17.4 Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments
12.18 TIANJIN PACIFIC PHARMACEUTICAL
12.18.1 TIANJIN PACIFIC PHARMACEUTICAL Corporation Information
12.18.2 TIANJIN PACIFIC PHARMACEUTICAL Overview
12.18.3 TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.18.4 TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 TIANJIN PACIFIC PHARMACEUTICAL Recent Developments
12.19 Shandong Xinhua Pharmaceutica Group
12.19.1 Shandong Xinhua Pharmaceutica Group Corporation Information
12.19.2 Shandong Xinhua Pharmaceutica Group Overview
12.19.3 Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.19.4 Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 Shandong Xinhua Pharmaceutica Group Recent Developments
12.20 Jiangsu Lianhuan Pharmaceutical
12.20.1 Jiangsu Lianhuan Pharmaceutical Corporation Information
12.20.2 Jiangsu Lianhuan Pharmaceutical Overview
12.20.3 Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.20.4 Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Jiangsu Lianhuan Pharmaceutical Recent Developments
12.21 Shanghai New Hualian Pharmaceutical
12.21.1 Shanghai New Hualian Pharmaceutical Corporation Information
12.21.2 Shanghai New Hualian Pharmaceutical Overview
12.21.3 Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.21.4 Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.21.5 Shanghai New Hualian Pharmaceutical Recent Developments
12.22 Shandong Taihua Biotech
12.22.1 Shandong Taihua Biotech Corporation Information
12.22.2 Shandong Taihua Biotech Overview
12.22.3 Shandong Taihua Biotech Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.22.4 Shandong Taihua Biotech Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.22.5 Shandong Taihua Biotech Recent Developments
12.23 Saituo Biological Technology
12.23.1 Saituo Biological Technology Corporation Information
12.23.2 Saituo Biological Technology Overview
12.23.3 Saituo Biological Technology Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.23.4 Saituo Biological Technology Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.23.5 Saituo Biological Technology Recent Developments
12.24 Zhejiang Xianju Junye Pharmaceutical
12.24.1 Zhejiang Xianju Junye Pharmaceutical Corporation Information
12.24.2 Zhejiang Xianju Junye Pharmaceutical Overview
12.24.3 Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.24.4 Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
12.24.5 Zhejiang Xianju Junye Pharmaceutical Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 Adrenocortical Hormones API Industry Chain Analysis
13.2 Adrenocortical Hormones API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Adrenocortical Hormones API Production Mode & Process
13.4 Adrenocortical Hormones API Sales and Marketing
13.4.1 Adrenocortical Hormones API Sales Channels
13.4.2 Adrenocortical Hormones API Distributors
13.5 Adrenocortical Hormones API Customers

14 Adrenocortical Hormones API Market Dynamics
14.1 Adrenocortical Hormones API Industry Trends
14.2 Adrenocortical Hormones API Market Drivers
14.3 Adrenocortical Hormones API Market Challenges
14.4 Adrenocortical Hormones API Market Restraints

15 Key Findings in the Global Adrenocortical Hormones API Study

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Adrenocortical Hormones API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Key Manufacturers of Prednisone Series
 Table 3. Key Manufacturers of Dexamethasone Series
 Table 4. Key Manufacturers of Betamethasone Series
 Table 5. Key Manufacturers of Hydrocortisone Series
 Table 6. Key Manufacturers of Others
 Table 7. Global Adrenocortical Hormones API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 8. Global Adrenocortical Hormones API Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 9. Global Production by Region (2020-2031) & (Tons)
 Table 10. Global Production Market Share by Region (2020-2031)
 Table 11. Global Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 12. Global Revenue by Region (2020-2031) & (US$ Million)
 Table 13. Global Revenue Market Share by Region (2020-2031)
 Table 14. Global Adrenocortical Hormones API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 15. Global Adrenocortical Hormones API Sales by Region (2020-2031) & (Tons)
 Table 16. Global Sales Market Share by Region (2020-2031)
 Table 17. Global Adrenocortical Hormones API Sales by Manufacturers (2020-2025) & (Tons)
 Table 18. Global Adrenocortical Hormones API Sales Share by Manufacturers (2020-2025)
 Table 19. Global Adrenocortical Hormones API Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 20. Global Adrenocortical Hormones API Revenue Market Share by Manufacturers (2020-2025)
 Table 21. Adrenocortical Hormones API Price by Manufacturers (2020-2025) & (US$/kg)
 Table 22. Global Key Players of Adrenocortical Hormones API, Industry Ranking, 2023 VS 2024
 Table 23. Global Adrenocortical Hormones API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 24. Global Adrenocortical Hormones API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenocortical Hormones API as of 2024)
 Table 25. Global Key Manufacturers of Adrenocortical Hormones API, Manufacturing Base Distribution and Headquarters
 Table 26. Global Key Manufacturers of Adrenocortical Hormones API, Product Offered and Application
 Table 27. Global Key Manufacturers of Adrenocortical Hormones API, Date of Enter into This Industry
 Table 28. Mergers & Acquisitions, Expansion Plans
 Table 29. Global Adrenocortical Hormones API Sales by Type (2020-2025) & (Tons)
 Table 30. Global Adrenocortical Hormones API Sales by Type (2026-2031) & (Tons)
 Table 31. Global Sales Share by Type (2020-2031)
 Table 32. Global Adrenocortical Hormones API Revenue by Type (2020-2025) & (US$ Million)
 Table 33. Global Adrenocortical Hormones API Revenue by Type (2026-2031) & (US$ Million)
 Table 34. Global Revenue Share by Type (2020-2031)
 Table 35. Adrenocortical Hormones API Price by Type (2020-2025) & (US$/kg)
 Table 36. Global Adrenocortical Hormones API Price Forecast by Type (2026-2031) & (US$/kg)
 Table 37. Global Adrenocortical Hormones API Sales by Application (2020-2025) & (Tons)
 Table 38. Global Adrenocortical Hormones API Sales by Application (2026-2031) & (Tons)
 Table 39. Global Sales Share by Application (2020-2031)
 Table 40. Global Adrenocortical Hormones API Revenue by Application (2020-2025) & (US$ Million)
 Table 41. Global Adrenocortical Hormones API Revenue by Application (2026-2031) & (US$ Million)
 Table 42. Global Revenue Share by Application (2020-2031)
 Table 43. Adrenocortical Hormones API Price by Application (2020-2025) & (US$/kg)
 Table 44. Global Adrenocortical Hormones API Price Forecast by Application (2026-2031) & (US$/kg)
 Table 45. US & Canada Sales by Type (2020-2031) & (Tons)
 Table 46. US & Canada Revenue by Type (2020-2031) & (US$ Million)
 Table 47. US & Canada Sales by Application (2020-2031) & (Tons)
 Table 48. US & Canada Revenue by Application (2020-2031) & (US$ Million)
 Table 49. US & Canada Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 50. US & Canada Revenue by Country (2020-2031) & (US$ Million)
 Table 51. US & Canada Sales by Country (2020-2031) & (Tons)
 Table 52. Europe Sales by Type (2020-2031) & (Tons)
 Table 53. Europe Revenue by Type (2020-2031) & (US$ Million)
 Table 54. Europe Sales by Application (2020-2031) & (Tons)
 Table 55. Europe Revenue by Application (2020-2031) & (US$ Million)
 Table 56. Europe Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 57. Europe Sales by Country (2020-2031) & (Tons)
 Table 58. Europe Revenue by Country (2020-2031) & (US$ Million)
 Table 59. China Sales by Type (2020-2031) & (Tons)
 Table 60. China Revenue by Type (2020-2031) & (US$ Million)
 Table 61. China Sales by Application (2020-2031) & (Tons)
 Table 62. China Revenue by Application (2020-2031) & (US$ Million)
 Table 63. Asia Sales by Type (2020-2031) & (Tons)
 Table 64. Asia Revenue by Type (2020-2031) & (US$ Million)
 Table 65. Asia Sales by Application (2020-2031) & (Tons)
 Table 66. Asia Revenue by Application (2020-2031) & (US$ Million)
 Table 67. Asia Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 68. Asia Revenue by Region (2020-2031) & (US$ Million)
 Table 69. Asia Sales by Region (2020-2031) & (Tons)
 Table 70. Middle East, Africa and Latin America Sales by Type (2020-2031) & (Tons)
 Table 71. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)
 Table 72. Middle East, Africa and Latin America Sales by Application (2020-2031) & (Tons)
 Table 73. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)
 Table 74. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 75. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)
 Table 76. Middle East, Africa and Latin America Sales by Country (2020-2031) & (Tons)
 Table 77. Pfizer CentreOne Corporation Information
 Table 78. Pfizer CentreOne Description and Major Businesses
 Table 79. Pfizer CentreOne Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 80. Pfizer CentreOne Product Model Numbers, Pictures, Descriptions and Specifications
 Table 81. Pfizer CentreOne Recent Developments
 Table 82. EUROAPI Corporation Information
 Table 83. EUROAPI Description and Major Businesses
 Table 84. EUROAPI Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 85. EUROAPI Product Model Numbers, Pictures, Descriptions and Specifications
 Table 86. EUROAPI Recent Developments
 Table 87. GlaxoSmithKline Corporation Information
 Table 88. GlaxoSmithKline Description and Major Businesses
 Table 89. GlaxoSmithKline Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 90. GlaxoSmithKline Product Model Numbers, Pictures, Descriptions and Specifications
 Table 91. GlaxoSmithKline Recent Developments
 Table 92. Teva Pharmaceutical Industries Corporation Information
 Table 93. Teva Pharmaceutical Industries Description and Major Businesses
 Table 94. Teva Pharmaceutical Industries Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 95. Teva Pharmaceutical Industries Product Model Numbers, Pictures, Descriptions and Specifications
 Table 96. Teva Pharmaceutical Industries Recent Developments
 Table 97. Hovione Corporation Information
 Table 98. Hovione Description and Major Businesses
 Table 99. Hovione Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 100. Hovione Product Model Numbers, Pictures, Descriptions and Specifications
 Table 101. Hovione Recent Developments
 Table 102. Axplora Corporation Information
 Table 103. Axplora Description and Major Businesses
 Table 104. Axplora Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 105. Axplora Product Model Numbers, Pictures, Descriptions and Specifications
 Table 106. Axplora Recent Developments
 Table 107. Steroid SpA Corporation Information
 Table 108. Steroid SpA Description and Major Businesses
 Table 109. Steroid SpA Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 110. Steroid SpA Product Model Numbers, Pictures, Descriptions and Specifications
 Table 111. Steroid SpA Recent Developments
 Table 112. Avik Pharmaceutical Corporation Information
 Table 113. Avik Pharmaceutical Description and Major Businesses
 Table 114. Avik Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 115. Avik Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 116. Avik Pharmaceutical Recent Developments
 Table 117. Anuh Pharma Corporation Information
 Table 118. Anuh Pharma Description and Major Businesses
 Table 119. Anuh Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 120. Anuh Pharma Product Model Numbers, Pictures, Descriptions and Specifications
 Table 121. Anuh Pharma Recent Developments
 Table 122. Symbiotec Pharmalab Corporation Information
 Table 123. Symbiotec Pharmalab Description and Major Businesses
 Table 124. Symbiotec Pharmalab Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 125. Symbiotec Pharmalab Product Model Numbers, Pictures, Descriptions and Specifications
 Table 126. Symbiotec Pharmalab Recent Developments
 Table 127. Sun Pharmaceutical Corporation Information
 Table 128. Sun Pharmaceutical Description and Major Businesses
 Table 129. Sun Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 130. Sun Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 131. Sun Pharmaceutical Recent Developments
 Table 132. Cipla Corporation Information
 Table 133. Cipla Description and Major Businesses
 Table 134. Cipla Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 135. Cipla Product Model Numbers, Pictures, Descriptions and Specifications
 Table 136. Cipla Recent Developments
 Table 137. Wellona Pharma Corporation Information
 Table 138. Wellona Pharma Description and Major Businesses
 Table 139. Wellona Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 140. Wellona Pharma Product Model Numbers, Pictures, Descriptions and Specifications
 Table 141. Wellona Pharma Recent Developments
 Table 142. Tianjin Tianyao Pharmaceuticals Corporation Information
 Table 143. Tianjin Tianyao Pharmaceuticals Description and Major Businesses
 Table 144. Tianjin Tianyao Pharmaceuticals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 145. Tianjin Tianyao Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
 Table 146. Tianjin Tianyao Pharmaceuticals Recent Developments
 Table 147. Zhejiang Xianju Pharmaceutical Corporation Information
 Table 148. Zhejiang Xianju Pharmaceutical Description and Major Businesses
 Table 149. Zhejiang Xianju Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 150. Zhejiang Xianju Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 151. Zhejiang Xianju Pharmaceutical Recent Developments
 Table 152. Guangdong Vtr Bio-Tech Corporation Information
 Table 153. Guangdong Vtr Bio-Tech Description and Major Businesses
 Table 154. Guangdong Vtr Bio-Tech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 155. Guangdong Vtr Bio-Tech Product Model Numbers, Pictures, Descriptions and Specifications
 Table 156. Guangdong Vtr Bio-Tech Recent Developments
 Table 157. Zhejiang Xianju Xianle Pharmaceutical Corporation Information
 Table 158. Zhejiang Xianju Xianle Pharmaceutical Description and Major Businesses
 Table 159. Zhejiang Xianju Xianle Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 160. Zhejiang Xianju Xianle Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 161. Zhejiang Xianju Xianle Pharmaceutical Recent Developments
 Table 162. TIANJIN PACIFIC PHARMACEUTICAL Corporation Information
 Table 163. TIANJIN PACIFIC PHARMACEUTICAL Description and Major Businesses
 Table 164. TIANJIN PACIFIC PHARMACEUTICAL Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 165. TIANJIN PACIFIC PHARMACEUTICAL Product Model Numbers, Pictures, Descriptions and Specifications
 Table 166. TIANJIN PACIFIC PHARMACEUTICAL Recent Developments
 Table 167. Shandong Xinhua Pharmaceutica Group Corporation Information
 Table 168. Shandong Xinhua Pharmaceutica Group Description and Major Businesses
 Table 169. Shandong Xinhua Pharmaceutica Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 170. Shandong Xinhua Pharmaceutica Group Product Model Numbers, Pictures, Descriptions and Specifications
 Table 171. Shandong Xinhua Pharmaceutica Group Recent Developments
 Table 172. Jiangsu Lianhuan Pharmaceutical Corporation Information
 Table 173. Jiangsu Lianhuan Pharmaceutical Description and Major Businesses
 Table 174. Jiangsu Lianhuan Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 175. Jiangsu Lianhuan Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 176. Jiangsu Lianhuan Pharmaceutical Recent Developments
 Table 177. Shanghai New Hualian Pharmaceutical Corporation Information
 Table 178. Shanghai New Hualian Pharmaceutical Description and Major Businesses
 Table 179. Shanghai New Hualian Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 180. Shanghai New Hualian Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 181. Shanghai New Hualian Pharmaceutical Recent Developments
 Table 182. Shandong Taihua Biotech Corporation Information
 Table 183. Shandong Taihua Biotech Description and Major Businesses
 Table 184. Shandong Taihua Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 185. Shandong Taihua Biotech Product Model Numbers, Pictures, Descriptions and Specifications
 Table 186. Shandong Taihua Biotech Recent Developments
 Table 187. Saituo Biological Technology Corporation Information
 Table 188. Saituo Biological Technology Description and Major Businesses
 Table 189. Saituo Biological Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 190. Saituo Biological Technology Product Model Numbers, Pictures, Descriptions and Specifications
 Table 191. Saituo Biological Technology Recent Developments
 Table 192. Zhejiang Xianju Junye Pharmaceutical Corporation Information
 Table 193. Zhejiang Xianju Junye Pharmaceutical Description and Major Businesses
 Table 194. Zhejiang Xianju Junye Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 195. Zhejiang Xianju Junye Pharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
 Table 196. Zhejiang Xianju Junye Pharmaceutical Recent Developments
 Table 197. Key Raw Materials Lists
 Table 198. Raw Materials Key Suppliers Lists
 Table 199. Distributors List
 Table 200. Customers List
 Table 201. Market Trends
 Table 202. Market Drivers
 Table 203. Market Challenges
 Table 204. Market Restraints
 Table 205. Research Programs/Design for This Report
 Table 206. Key Data Information from Secondary Sources
 Table 207. Key Data Information from Primary Sources


List of Figures
 Figure 1. Adrenocortical Hormones API Product Picture
 Figure 2. Global Adrenocortical Hormones API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Adrenocortical Hormones API Market Share by Type: 2024 & 2031
 Figure 4. Prednisone Series Product Picture
 Figure 5. Dexamethasone Series Product Picture
 Figure 6. Betamethasone Series Product Picture
 Figure 7. Hydrocortisone Series Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Adrenocortical Hormones API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 10. Global Adrenocortical Hormones API Market Share by Application in 2024 & 2031
 Figure 11. Injectable Drugs
 Figure 12. Oral Drugs
 Figure 13. Topical Drugs
 Figure 14. Inhaled Drugs
 Figure 15. Adrenocortical Hormones API Report Years Considered
 Figure 16. Global Adrenocortical Hormones API Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 17. Global Adrenocortical Hormones API Production by Region (2020 – 2031) (Tons)
 Figure 18. Global Adrenocortical Hormones API Production Market Share by Region in Percentage: 2024 Versus 2031
 Figure 19. Global Adrenocortical Hormones API Production Market Share by Region (2020-2031)
 Figure 20. Adrenocortical Hormones API Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 21. Adrenocortical Hormones API Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 22. Adrenocortical Hormones API Production Growth Rate in China (2020-2031) & (Tons)
 Figure 23. Adrenocortical Hormones API Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 24. Adrenocortical Hormones API Production Growth Rate in Southeast Asia (2020-2031) & (Tons)
 Figure 25. Adrenocortical Hormones API Production Growth Rate in India (2020-2031) & (Tons)
 Figure 26. Global Adrenocortical Hormones API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 27. Global Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 28. Global Adrenocortical Hormones API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 29. Global Adrenocortical Hormones API Revenue Market Share by Region in Percentage: 2024 Versus 2031
 Figure 30. Global Adrenocortical Hormones API Revenue Market Share by Region (2020-2031)
 Figure 31. Global Adrenocortical Hormones API Sales (2020-2031) & (Tons)
 Figure 32. Global Adrenocortical Hormones API Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 33. Global Adrenocortical Hormones API Sales Market Share by Region (2020-2031)
 Figure 34. US & Canada Adrenocortical Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 35. US & Canada Adrenocortical Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Europe Adrenocortical Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 37. Europe Adrenocortical Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. China Adrenocortical Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 39. China Adrenocortical Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Asia (excluding China) Adrenocortical Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 41. Asia (excluding China) Adrenocortical Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Middle East, Africa and Latin America Adrenocortical Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 43. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 44. Global Adrenocortical Hormones API Sales Share by Manufacturers (2024)
 Figure 45. The Adrenocortical Hormones API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
 Figure 46. Global Adrenocortical Hormones API Revenue Share by Manufacturers (2024)
 Figure 47. The Top 5 and 10 Largest Manufacturers of Adrenocortical Hormones API in the World: Market Share by Adrenocortical Hormones API Revenue in 2024
 Figure 48. Global Adrenocortical Hormones API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 49. Global Adrenocortical Hormones API Sales Market Share by Type (2020-2031)
 Figure 50. Global Adrenocortical Hormones API Revenue Market Share by Type (2020-2031)
 Figure 51. Global Adrenocortical Hormones API Sales Market Share by Application (2020-2031)
 Figure 52. Global Adrenocortical Hormones API Revenue Market Share by Application (2020-2031)
 Figure 53. US & Canada Adrenocortical Hormones API Sales Market Share by Type (2020-2031)
 Figure 54. US & Canada Adrenocortical Hormones API Revenue Market Share by Type (2020-2031)
 Figure 55. US & Canada Adrenocortical Hormones API Sales Market Share by Application (2020-2031)
 Figure 56. US & Canada Adrenocortical Hormones API Revenue Market Share by Application (2020-2031)
 Figure 57. US & Canada Adrenocortical Hormones API Revenue Share by Country (2020-2031)
 Figure 58. US & Canada Adrenocortical Hormones API Sales Share by Country (2020-2031)
 Figure 59. US Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 60. Canada Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 61. Europe Adrenocortical Hormones API Sales Market Share by Type (2020-2031)
 Figure 62. Europe Adrenocortical Hormones API Revenue Market Share by Type (2020-2031)
 Figure 63. Europe Adrenocortical Hormones API Sales Market Share by Application (2020-2031)
 Figure 64. Europe Adrenocortical Hormones API Revenue Market Share by Application (2020-2031)
 Figure 65. Europe Adrenocortical Hormones API Sales Share by Country (2020-2031)
 Figure 66. Europe Adrenocortical Hormones API Revenue Share by Country (2020-2031)
 Figure 67. Germany Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 68. France Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 69. U.K. Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 70. Italy Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 71. Russia Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 72. China Adrenocortical Hormones API Sales Market Share by Type (2020-2031)
 Figure 73. China Adrenocortical Hormones API Revenue Market Share by Type (2020-2031)
 Figure 74. China Adrenocortical Hormones API Sales Market Share by Application (2020-2031)
 Figure 75. China Adrenocortical Hormones API Revenue Market Share by Application (2020-2031)
 Figure 76. Asia Adrenocortical Hormones API Sales Market Share by Type (2020-2031)
 Figure 77. Asia Adrenocortical Hormones API Revenue Market Share by Type (2020-2031)
 Figure 78. Asia Adrenocortical Hormones API Sales Market Share by Application (2020-2031)
 Figure 79. Asia Adrenocortical Hormones API Revenue Market Share by Application (2020-2031)
 Figure 80. Asia Adrenocortical Hormones API Revenue Share by Region (2020-2031)
 Figure 81. Asia Adrenocortical Hormones API Sales Share by Region (2020-2031)
 Figure 82. Japan Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 83. South Korea Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 84. China Taiwan Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 85. Southeast Asia Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 86. India Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 87. Middle East, Africa and Latin America Adrenocortical Hormones API Sales Market Share by Type (2020-2031)
 Figure 88. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue Market Share by Type (2020-2031)
 Figure 89. Middle East, Africa and Latin America Adrenocortical Hormones API Sales Market Share by Application (2020-2031)
 Figure 90. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue Market Share by Application (2020-2031)
 Figure 91. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue Share by Country (2020-2031)
 Figure 92. Middle East, Africa and Latin America Adrenocortical Hormones API Sales Share by Country (2020-2031)
 Figure 93. Brazil Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 94. Mexico Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 95. Turkey Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 96. Israel Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 97. GCC Countries Adrenocortical Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 98. Value Chain
 Figure 99. Adrenocortical Hormones API Production Process
 Figure 100. Channels of Distribution (Direct Vs Distribution)
 Figure 101. Bottom-up and Top-down Approaches for This Report
 Figure 102. Data Triangulation
 Figure 103. Key Executives Interviewed

以下、関連資料のご紹介